Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC35G3 is a member of the SLC35 family of nucleotide sugar transporters found predominantly in the testis, localized to the Golgi apparatus of early round spermatids. It is a multi-pass transmembrane protein responsible for transporting UDP-N-acetylglucosamine into the Golgi, enabling the glycosylation of critical sperm membrane proteins, including those involved in acrosome formation and zona pellucida binding. Mouse SLC35G3 knockout models are sterile due to failure in sperm transit and fertilization processes. Human mutations in SLC35G3 diminish its transporter activity and are associated with male infertility risk. SLC35G3 is thus essential for sperm membrane protein glycosylation and male reproductive fitness. Key references for structure, function, and disease role include functional genetic studies in mice, protein biochemical analysis, and human variant association with infertility. No therapeutic agents currently target SLC35G3, but it may serve as a biomarker for specific infertility syndromes related to glycoprotein processing in sperm.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 35 member G3 (SLC35G3).